Tag Archives: NeuroVive Pharmaceutical

Brain Cell Care After TBI

From Combat & Casualty Care, Q1 2019 Issue

A medical research company has shown an early signal of brain cell protection in traumatic brain injury (TBI) patients with its repurposed drug and is now progressing the preventive treatment program into advanced clinical trials.

By Steve Campbell, Campbell & Company Strategies Inc.

(more…)